Add to a list

Inactive Instrument

LOTUS PHARM Stock OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Market Cap	9.74M 8.49M 7.85M 7.36M 13.78M 918M 13.89M 93.21M 36.12M 452M 36.54M 35.76M 1.57B	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	14.38M 12.54M 11.6M 10.87M 20.35M 1.36B 20.51M 138M 53.36M 668M 53.98M 52.82M 2.32B	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
21-09-28	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
12-05-16	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
12-04-19	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

12-30	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
25-10-06	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
25-08-12	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
25-02-21	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
24-11-08	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.74%	+1.69%	+11.57%	+83.50%	46.74B
OTSUKA HOLDINGS CO., LTD.	-2.91%	+3.09%	+49.98%	+91.04%	34.33B
CIPLA LIMITED	-0.27%	-2.71%	-8.91%	+33.68%	11.57B
ZYDUS LIFESCIENCES LIMITED	-0.34%	-3.07%	+12.71%	+93.23%	11.42B
KRKA, D. D.	-0.57%	+0.96%	+38.89%	+128.26%	9.09B
GEDEON RICHTER	+0.43%	-1.68%	+14.22%	+40.48%	6.98B
ONO PHARMACEUTICAL CO., LTD.	-1.23%	+1.65%	+43.80%	-18.26%	6.55B
GLENMARK PHARMACEUTICALS LIMITED	+2.77%	+1.83%	+35.04%	+245.66%	6.62B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.73%	-2.94%	-36.14%	-5.18%	5B
Average	-0.07%	+0.08%	+17.91%	+76.93%	15.37B
Weighted average by Cap.	-0.44%	+0.99%	+22.34%	+82.51%

	2009	2010
Net sales	57.82M 50.42M 46.63M 43.7M 81.83M 5.45B 82.48M 554M 215M 2.68B 217M 212M 9.33B	72.7M 63.39M 58.62M 54.94M 103M 6.86B 104M 696M 270M 3.38B 273M 267M 11.72B
Net income	16.43M 14.33M 13.25M 12.42M 23.25M 1.55B 23.44M 157M 60.96M 763M 61.67M 60.35M 2.65B	14.42M 12.58M 11.63M 10.9M 20.41M 1.36B 20.57M 138M 53.51M 670M 54.14M 52.98M 2.33B
Net Debt	5.29 4.62 4.27 4 7.49 499.26 7.55 50.68 19.64 245.79 19.87 19.44 853.77	4.65 4.05 3.75 3.51 6.58 438.23 6.63 44.49 17.24 215.74 17.44 17.07 749.4

LOTUS PHARM Stock OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news : LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile